CLYMClimb Bio Inc. Common Stock
17.28USD-0.35%Mkt Cap: 992.50M $P/E: —3d ago
Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases. The company's lead product candidate is the budoprutug, a…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap992.50M $
Enterprise Value795.76M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-59.85M $
Revenue/Share—
Last Price17.28 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-16.12
PEG—
EV/EBITDA-12.31
EV/Revenue—
P/S—
P/B4.08
EPS (TTM)-0.80
EPS (Forward)-1.06
52W Range
1.54095% of range18.14
52W High18.14 USD
52W Low1.540 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-37.30%
ROA-35.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.36M $
CapEx (TTM)186.00K $
FCF Margin—
FCF Yield-3.42%
Net Debt-181.81M $
Net Debt/EBITDA2.81
Balance Sheet
Debt/Equity0.00
Current Ratio31.45
Quick Ratio30.86
Book Value/Sh4.171 USD
Cash/Share3.188 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)22.57 USD
Upside (mean)+30.6%
Target Range18.00 USD – 35.00 USD
$18.00+30.6% to mean$35.00
# Analysts14
Ownership
Shares Out.57.44M
Float41.60M
Insiders0.37%
Institutions105.23%
Short Interest
Short Ratio5.8d
Short % Float17.28%
Short % Out.12.25%
Shares Short7.04M
Short (prev mo.)5.10M
Technical
SMA 5013.18 (+31.1%)
SMA 2007.959 (+117.1%)
Beta0.08
S&P 52W Chg18.16%
Avg Vol (30d)1.13M
Avg Vol (10d)1.30M
Technical Indicators
RSI (14)76.4
MACD1.1470
MACD Signal0.6748
MACD Hist.+0.4722
BB Upper17.60 USD
BB Middle13.83 USD
BB Lower10.05 USD
BB Width54.59%
ATR (14)1.106 USD
Vol Ratio (20d)0.85x